Christine Quern is the founder of CBQ Communications, a firm specializing in marketing communications and public relations services for life sciences companies. With extensive experience in conceptualizing and implementing strategic communications programs, Christine has worked with B2B life sciences companies as well as biotech, pharma, device, and diagnostics companies. Her expertise includes creating marketing, PR, and thought leadership strategies, positioning and messaging designed to achieve impactful results. She excels in exploring the competitive landscape and understanding the voice of the customer through audits and market research, which reveal new insights and enable differentiated storytelling.

​

Christine is adept at executing communications programs that create awareness, gain entry into the buyer’s consideration set, support the sales process, and strengthen relationships with customers. She also develops content to drive thought leadership and educate audiences, ranging from bylines and op-eds to application notes, backgrounders, and case studies. Her impressive client list includes notable names such as Alnylam, Asher Bio, ATCC, Corning Life Sciences, CytomX, Illumina, Insightec, Lawrence Berkeley Labs, Life Technologies (now Thermo), Merck KGaA/MilliporeSigma, Merus, Mirus, Minaris, Selecta Biosciences, Texas A&M Center for Advanced Biodevelopment, and USP.